A new wave of cancer treatments is looking promising for the future of oncologic care. The ovarian cancer drug RC88, which is made by the Chinese biopharmaceutical company RemeGen, received FDA ...
FDA fast-tracks VS-7375, an oral KRAS G12D inhibitor, opening new hope for pretreated advanced NSCLC and fueling pivotal ...
The Fast Track designation is designed to help promising medicines for serious diseases reach patients faster by allowing ...
A second dendritic cell vaccine has received fast track designation from the Food and Drug Administration. The Food and Drug Administration (FDA) has granted a fast track designation to a dendritic ...
A newly identified colon cancer gene may drive the disease by making the environment in the vicinity of tumors more hospitable to them, researchers say. The gene, which appears to speed tumor growth ...
Hosted on MSN
Study: One-week breast cancer radiotherapy proven as safe and effective as standard three-week treatment
Presented at ESTRO 2025 in Vienna, Austria, a 10-year study involving over 4,000 UK patients confirms that a one-week course of post-surgery radiotherapy is just as safe and effective as the ...
The Fast Company Impact Council is an invitation-only membership community of top leaders and experts who pay dues for access to peer learning, thought leadership, and more. BY Jurgi Camblong Cancer ...
A research team in the Department of Pharmacology and Pharmacy at the LKS Faculty of Medicine of the University of Hong Kong (HKUMed), has conducted a pioneering study that found an association ...
The landscape of cancer prevention has been dramatically illuminated by groundbreaking research from the American Cancer Society, revealing that over 40% of cancer cases in adults over 30 are linked ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results